The oil market is looking for subtle signals on the Iran nuclear deal. The latest is from the White House, with the press secretary saying it will agree to a deal if it's in the US' interest.
Oil doesn't like it and it's testing yesterday's lows:
ADVERTISEMENT - CONTINUE READING BELOW
Search investingLive
Directory
White House doesn't rule out agreeing to Iran nuclear deal
- Oil lower
ADVERTISEMENT - CONTINUE READING BELOW
- Tags
- Oil
Most Popular
- FT: Trump is pushing for 15 – 20% minimum tariff on all EU goods. EURUSD moves lower.
- API oil chief warns US Strategic Petroleum Reserve nearing critical low
- US May CPI forecasts from 15 investment bank analysts. Hot, hot, hot ... FOMC sweating.
- Trump says going to "win it over the next two weeks". Usual lies and bluster?
- OpenAI files confidential IPO prospectus, suspected September market debut
- investingLive Americas FX news wrap 8 Jun: Dollar mixed as yields rise and stocks split
- BofA warns 70% of bear market signals now triggered for S&P 500
ADVERTISEMENT - CONTINUE READING BELOW
Best in 2026
Sponsored
ADVERTISEMENT - CONTINUE READING BELOW
ADVERTISEMENT - CONTINUE READING BELOW
Telegram Community
Gain Access
API CEO Mike Sommers warns the US SPR is approaching operationally critical levels at 350 million barrels, with gasoline stocks already down 38 million barrels, urging rapid reopening of the Strait of Hormuz.
investingLive Exclusive
16m ago
US May CPI due Wednesday is seen as a critical test ahead of the June 17 Fed decision, with money markets pricing a 98% chance of a rate hike by December amid persistent inflation.
investingLive Exclusive
36m ago
Intel's stock jumps on Google's reported AI chip foundry order, signaling a potential revival and boosting its valuation.
Investor's Business Daily
37m ago
Trump says going to "win it over the next two weeks". Usual lies and bluster? Trump spoke at a tele-rally
investingLive Exclusive
1h ago
Intel jumps on reports of Google & Nvidia foundry deals. AI race could spark revival, boosting its valuation.
YahooFinance
1h ago
Tango's cancer drug combo hits 92% response rate! Stock jumps on promising clinical data.
statnews
1h ago
Novo Nordisk shares dip 3.2% despite promising diabetes data; CEO eyes longevity & aesthetics.
YahooFinance
1h ago
Telegram Community
Gain Access
Best in 2026
Sponsored
Must Read
!"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|} !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}